Published in Am J Physiol on March 01, 1993
Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases. J Clin Invest (1998) 1.05
β-adrenergic receptor responsiveness in aging heart and clinical implications. Front Physiol (2014) 0.93
Effects of exercise training on cardiovascular adrenergic system. Front Physiol (2013) 0.88
The Role of Exercise in Cardiac Aging: From Physiology to Molecular Mechanisms. Circ Res (2016) 0.87
The effects of exercise training on myocardial adrenergic and muscarinic receptors. Clin Auton Res (2006) 0.81
Voluntary exercise-induced changes in beta2-adrenoceptor signalling in rat ventricular myocytes. Exp Physiol (2008) 0.79
Cardiac β-adrenergic responsiveness with exercise. Eur J Appl Physiol (2011) 0.77
Optimizing cardiovascular benefits of exercise: a review of rodent models. Int J Angiol (2013) 0.76
Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation (1993) 4.52
Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation (1992) 3.46
Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res (1993) 2.94
[Determining the current position regarding the value of pioglitazone for the therapy of diabetes]. Dtsch Med Wochenschr (2007) 2.67
An atypical variant of Fabry's disease with manifestations confined to the myocardium. N Engl J Med (1991) 2.27
[The central venous catheter. Approach to the subclavian vein]. Dtsch Med Wochenschr (2007) 2.04
[Ascites paracentesis]. Dtsch Med Wochenschr (2007) 2.03
A prognostic computer model to individually predict post-procedural complications in interventional cardiology: the INTERVENT Project. Eur Heart J (1999) 1.98
The event-related P300 potential approach to cognitive functions of nondemented patients with cerebral and peripheral arteriosclerosis. J Am Geriatr Soc (1995) 1.94
Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety. Europace (2007) 1.73
Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. Circ Res (1994) 1.66
Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol (1998) 1.64
CT and MR evaluation of pericardial constriction: a new diagnostic and therapeutic concept. J Thorac Imaging (1993) 1.64
Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation. J Mol Cell Cardiol (1999) 1.63
Accelerated glial reactivity to stroke in aged rats correlates with reduced functional recovery. J Cereb Blood Flow Metab (2003) 1.62
A prognostic computer model to predict individual outcome in interventional cardiology. The INTERVENT Project. Eur Heart J (1997) 1.61
Fully reversible pulmonary arterial hypertension associated with dasatinib treatment for chronic myeloid leukaemia. Eur Respir J (2011) 1.60
[Adherence to guidelines in CHF therapy in Germany]. Dtsch Med Wochenschr (2005) 1.58
Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure. Circ Res (1993) 1.55
Congenitally corrected transposition of the great arteries (L-TGA) with situs inversus totalis in adulthood: findings with magnetic resonance imaging. Magn Reson Imaging (2000) 1.52
The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points. Eur J Heart Fail (2001) 1.49
Lipoteichoic acids from Streptococcus sanguis. J Bacteriol (1974) 1.43
Quantitative aspects of ouabain binding to human erythrocyte and cardiac membranes. J Physiol (1975) 1.42
Xamoterol and the failing heart. Lancet (1989) 1.41
Age-dependent changes of the kidneys: pharmacological implications. Gerontology (1999) 1.41
[About science and politics]. Dtsch Med Wochenschr (2003) 1.41
[Therapy with glitazones--a risk for cardiovascular disease?]. Dtsch Med Wochenschr (2007) 1.40
Improvement of myocardial blood flow to ischemic regions by angiotensin-converting enzyme inhibition with quinaprilat IV: a study using [15O] water dobutamine stress positron emission tomography. J Am Coll Cardiol (1999) 1.40
[Epileptic seizures: effects on cardiac function]. Dtsch Med Wochenschr (2011) 1.40
Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting. Swiss Med Wkly (2009) 1.39
[Dissection of the ramus interventricularis anterior in blunt chest trauma]. Dtsch Med Wochenschr (1999) 1.39
[Alcohol and myocardial infarct. Epidemiological and experimental studies on the effect of alcohol on vascular relaxation and coronary sclerosis]. Dtsch Med Wochenschr (1998) 1.39
[Stable angina pectoris can be treated successfully by drugs alone--pro]. Dtsch Med Wochenschr (2007) 1.38
[Death due to liver hemorrhage after infarct lysis]. Dtsch Med Wochenschr (1999) 1.38
[Missing medical care?]. Dtsch Med Wochenschr (2002) 1.38
[Clinical value of magnetic resonance tomography in imaging coronary stenoses. A comparison with coronary angiography and myocardial scintigraphy]. Dtsch Med Wochenschr (1999) 1.38
Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Am J Physiol (1997) 1.37
Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy. Circulation (1990) 1.36
The failing human heart is unable to use the Frank-Starling mechanism. Circ Res (1994) 1.31
[Guidelines for therapy of chronic heart failure]. Z Kardiol (2005) 1.24
Calcium content of the sarcoplasmic reticulum in isolated ventricular myocytes from patients with terminal heart failure. J Mol Cell Cardiol (1998) 1.22
Interleukin-6 and selected plasma proteins in healthy persons of different ages. Neurobiol Aging (1995) 1.20
Positive inotropism of vanadate in cat papillary muscle. Nature (1978) 1.18
Ca(2+)-currents and intracellular [Ca2+]i-transients in single ventricular myocytes isolated from terminally failing human myocardium. Basic Res Cardiol (1992) 1.18
Ouabain-receptor interactions in (Na + +K + )-ATPase preparations from different tissues and species. Determination of kinetic constants and dissociation constants. Biochim Biophys Acta (1973) 1.15
The event-related P300 potential analysis of cognitive human brain aging: a review. Gerontology (1993) 1.14
Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: progressive reduction of beta 1-adrenergic receptor mRNA in heart failure. J Am Coll Cardiol (1996) 1.12
Reduced sodium pump alpha1, alpha3, and beta1-isoform protein levels and Na+,K+-ATPase activity but unchanged Na+-Ca2+ exchanger protein levels in human heart failure. Circulation (1999) 1.11
Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium. Eur Heart J (1988) 1.10
Titin, myosin light chains and C-protein in the developing and failing human heart. J Mol Cell Cardiol (1994) 1.10
Ischemia-induced phosphorylation and translocation of stress protein alpha B-crystallin to Z lines of myocardium. Am J Physiol (1998) 1.09
Investigation of secretory immunoglobulins in saliva from germfree mice. Infect Immun (1974) 1.08
Cardiac glycoside receptor, (Na+ + K+)-ATPase activity and force of contraction in rat heart. Biochem Pharmacol (1980) 1.08
The emergence of pattern discovery techniques in computational biology. Metab Eng (2000) 1.07
Evidence against spare or uncoupled beta-adrenoceptors in the human heart. Am Heart J (1990) 1.06
Effects of vanadate in cultured rat heart muscle cells. Vanadate transport, intracellular binding and vanadate-induced changes in beating and in active cation flux. Biochim Biophys Acta (1980) 1.05
Effects of ribose on exercise-induced ischaemia in stable coronary artery disease. Lancet (1992) 1.04
Regional expression of sodium pump subunits isoforms and Na+-Ca++ exchanger in the human heart. J Clin Invest (1996) 1.04
Prevalence of aspirin resistance in patients with type 2 diabetes. Acta Diabetol (2005) 1.02
Structure-function relationship of a recombinant human galactoside-binding protein. Biochemistry (1993) 1.02
The effect of a garlic preparation on the composition of plasma lipoproteins and erythrocyte membranes in geriatric subjects. Br J Clin Pract Suppl (1990) 1.01
Changes in essential myosin light chain isoform expression provide a molecular basis for isometric force regulation in the failing human heart. J Mol Cell Cardiol (1997) 1.01
[Characteristics of patients with coronary ectasias with and without stenotic coronary artery disease]. Dtsch Med Wochenschr (2005) 1.01
Binding of the stress protein alpha B-crystallin to cardiac myofibrils correlates with the degree of myocardial damage during ischemia/reperfusion in vivo. J Mol Cell Cardiol (1999) 1.00
Characteristics of calcium-current in isolated human ventricular myocytes from patients with terminal heart failure. J Mol Cell Cardiol (1991) 0.99
Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. J Am Coll Cardiol (1996) 0.99
Stimulatory effect of vanadate on the adenylate cyclase of cardiac tissue. Biochem Pharmacol (1979) 0.99
Altered diastolic [Ca2+]i handling in human ventricular myocytes from patients with terminal heart failure. Am Heart J (1995) 0.99
Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium. Circ Res (1991) 0.99
Subsensitivity of the failing human heart to isoprenaline and milrinone is related to beta-adrenoceptor downregulation. J Cardiovasc Pharmacol (1988) 0.98
Alcohol and the risk of myocardial infarction. Basic Res Cardiol (2001) 0.97
Evidence for reduction of norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol (1995) 0.97
Fibrin degeneration product concentrations (D-dimers) in the course of ageing. Gerontology (1995) 0.97
Sequential appearance of salivary antibodies after oral immunization of axenic mice. Infect Immun (1975) 0.95
Beta 2-adrenoceptors in human lung and peripheral mononuclear leukocytes of untreated and terbutaline-treated patients. Chest (1990) 0.95
Effect of smoking on MAP kinase-induced modulation of IL-8 in human alveolar macrophages. Eur Respir J (2004) 0.94
The aging liver: structural and functional changes and their consequences for drug treatment in old age. Gerontology (2002) 0.94
cAMP concentrations, cAMP dependent protein kinase activity, and phospholamban in non-failing and failing myocardium. Cardiovasc Res (1994) 0.94
The biological significance of plasmalogens in defense against oxidative damage. Exp Gerontol (1998) 0.94
The influence of age and multimorbidity on the pharmacokinetics and metabolism of spironolactone. Arch Gerontol Geriatr (1984) 0.94
Echinococcus cyst located in the interventricular septum. Clin Res Cardiol (2006) 0.94
Inverse relationship between colonic (Na+ + K+)-ATPase activity and degree of mucosal inflammation in inflammatory bowel disease. Dig Dis Sci (1988) 0.93
Ouabain-receptor interactions in (Na+ plus K+)-ATPase preparations. IV. The molecular structure of different cardioactive steroids and other substances and their affinity to the glycoside receptor. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.93
Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity. Am Heart J (1990) 0.93
[Polypharmacy, compliance and non-prescription medication in patients with cardiovascular disease in Germany]. Dtsch Med Wochenschr (2007) 0.93
Accelerated accumulation of N- and C-terminal beta APP fragments and delayed recovery of microtubule-associated protein 1B expression following stroke in aged rats. Eur J Neurosci (2004) 0.92
Alpha-adrenoceptors and alpha-adrenoceptor-mediated positive inotropic effects in failing human myocardium. J Cardiovasc Pharmacol (1988) 0.92
ABO blood group system, age, sex, risk factors and cardiac infarction. Arch Gerontol Geriatr (1985) 0.92
Baseline characteristics of patients recruited into the CARE-HF study. Eur J Heart Fail (2005) 0.92
Increased number of ouabain binding sites in human erythrocyte membranes in chronic hypokalaemia. Acta Biol Med Ger (1977) 0.91
Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death. J Cardiovasc Pharmacol (2000) 0.91
Characterization of A1 adenosine receptors in atrial and ventricular myocardium from diseased human hearts. Circ Res (1989) 0.90
Stimulatory effect of vanadate on (Na+ + K+)-ATPase activity and on 3H-ouabain-binding in a cat heart cell membrane preparation. Nature (1979) 0.90
Beta-blocking agents in heart failure. Should they be used and how? Eur Heart J (1996) 0.90
Use of NT-proBNP in routine testing and comparison to BNP. Eur J Heart Fail (2004) 0.89
Effect of olsalazine and mesalazine on human ileal and colonic (Na+ + K+)-ATPase. A possible diarrhogenic factor? Clin Investig (1993) 0.89
Ouabain-receptor interactions in (Na+ + K+)-ATPase preparations. II. Effect of cations and nucleotides on rate constants and dissociation constants. Biochim Biophys Acta (1973) 0.89